# Clinical Estradiol Trial in Women With Schizophrenia

> **NCT00206570** · PHASE2 · COMPLETED · sponsor: **Bayside Health** · enrollment: 100 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder

## Interventions

- **DRUG:** Estradiol

## Key facts

- **NCT ID:** NCT00206570
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206570, "Clinical Estradiol Trial in Women With Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00206570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*